DNA

Some feared, that the patent decisions on the CRISPR technology this spring might lead to a monopolization of the technology. However, according to a last month's article in Nature Methods, it is not at all clear at this moment, whether CRISPR will hit a home run for the editing of the human genome.

Mostly we use the SnapGene software when we check the sequences of our DNA constructs.

I have read an interesting blog post by Steven Novella about biohacking.